BeiGene
Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.
BeiGene
Slide kit describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.
Poster presented at EHA2023, outlining the characterization of the safety/tolerability profile of two BTKis in patients with B-cell malignancies based on a post hoc analysis of a large clinical trial safety database.

Chat with BeiGene

Close